Tiny magnetic discs offer remote brain stimulation without transgenes
The devices could be a useful tool for biomedical research, and possible clinical use in the future.
The devices could be a useful tool for biomedical research, and possible clinical use in the future.
Inspired by traditional medicine, 17-year-old Tomás Orellana is on a mission to identify plants that can help treat students’ health issues.
The scientists, who worked together as postdocs at MIT, are honored for their discovery of microRNA — a class of molecules that are critical for gene regulation.
New statistical models based on physiological data from more than 100 surgeries provide objective, accurate measures of the body’s subconscious perception of pain.
Researchers argue that in health care settings, “responsible use” labels could ensure AI systems are deployed appropriately.
MIT scientists’ discovery yields a potent immune response, could be used to develop a potential tumor vaccine.
Hanna Adeyema and Carolina Haass-Koffler discuss the substance use disorder crisis and the future of innovation in the field.
MIT researchers investigate the neural circuits that underlie placebos’ ability to relieve chronic and acute pain.
By unraveling the genetic pathways that help Toxoplasma gondii persist in human cells, Sebastian Lourido hopes to find new ways to treat toxoplasmosis.
The new device, which can be implanted under the skin, rapidly releases naloxone when an overdose is detected.
A mathematical method, validated with experimental data, provides a fast, reliable, and minimally invasive way of determining how to treat critical blood pressure changes during surgery or intensive care.
Propofol, a drug commonly used for general anesthesia, derails the brain’s normal balance between stability and excitability.
By helping microbes withstand industrial processing, the method could make it easier to harness the benefits of microorganisms used as medicines and in agriculture.
The program focused on AI in health care, drawing on Takeda’s R&D experience in drug development and MIT’s deep expertise in AI.
Twelve finalists participated in initiative and 2023-24 MIT-Royalty Pharma Prize Competition, designed to support female biotech pioneers.